Tacrolimus prevents breast cancer growth in pre-clinical studies

[News]

Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE.

More... (http://www.news-medical.net/news/20110527/Tacrolimus-prevents-breast-cancer-growth-in-pre-clinical-studies.aspx)